This collaborative article reviews chronic pulmonary aspergillosis (CPA) from the perspective of a multidisciplinary team comprising of respiratory physicians, radiologists, mycologists, dietitians, pharmacists, physiotherapists and palliative care specialists. The review synthesises current knowledge on CPA, emphasising the intricate interplay between clinical, radiological, and microbiological aspects. We highlight the importance of assessing each patient as a multidisciplinary team to ensure personalised treatment strategies and a holistic approach to patient care.
Share this post
Latest News posts
How the NHS funds medications
February 25, 2025
Thinking about joining a clinical trial? What are your concerns?
December 12, 2024
Biologics & ABPA – what are they and what can they do?
October 19, 2024
UK National RSV vaccination program launched
July 26, 2024
HEPA filters & heat to reduce exposure to allergens
March 18, 2025
How the UK evaluates new drugs for use in the NHS
March 4, 2025
ABPA & CPA: Patient priorities
February 25, 2025
I Have ABPA and feel worse if I sleep with windows open
February 25, 2025
How the NHS funds medications
February 25, 2025
Thinking about joining a clinical trial? What are your concerns?
December 12, 2024
Biologics & ABPA – what are they and what can they do?
October 19, 2024
UK National RSV vaccination program launched
July 26, 2024
HEPA filters & heat to reduce exposure to allergens
March 18, 2025
How the UK evaluates new drugs for use in the NHS
March 4, 2025
ABPA & CPA: Patient priorities
February 25, 2025
I Have ABPA and feel worse if I sleep with windows open
February 25, 2025
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video